The Board of Directors of J.B. Chemicals & Pharmaceuticals Ltd. will meet on February 5, 2026, to consider the declaration of an interim dividend for the financial year 2025-26. This announcement signals a potential distribution of profits to shareholders and highlights the company’s financial performance.
Interim Dividend Meeting
The Board of Directors of J. B. Chemicals & Pharmaceuticals Ltd. is scheduled to convene on February 5, 2026. During this meeting, a key agenda item will be the consideration of an interim dividend for the financial year 2025-26.
Financial Year 2025-26 Dividend
Shareholders and investors are advised that the board will discuss and potentially approve the declaration of an Interim Dividend for the ongoing financial year 2025-26. The outcome of the board meeting will provide clarity on whether the company will distribute an interim dividend and the amount if approved.
Source: BSE
